Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 1
1963 2
1964 1
1965 1
1967 1
1968 1
1970 2
1973 2
1974 4
1975 1
1976 1
1977 1
1978 1
1979 2
1980 1
1982 1
1985 1
1986 1
1988 4
1991 1
1992 3
1994 1
1996 1
1997 2
1998 4
1999 3
2000 4
2001 8
2002 4
2003 9
2004 5
2005 6
2006 1
2007 6
2008 5
2009 6
2010 3
2011 3
2012 5
2013 2
2014 5
2015 4
2016 4
2017 5
2018 10
2019 10
2020 10
2021 4
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

155 results
Results by year
Filters applied: . Clear all
Page 1
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.
Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, Sher X, Liu XQ, Lu H, Nebozhyn M, Zhang C, Lunceford JK, Joe A, Cheng J, Webber AL, Ibrahim N, Plimack ER, Ott PA, Seiwert TY, Ribas A, McClanahan TK, Tomassini JE, Loboda A, Kaufman D. Cristescu R, et al. Among authors: ayers m. Science. 2018 Oct 12;362(6411):eaar3593. doi: 10.1126/science.aar3593. Science. 2018. PMID: 30309915 Free PMC article.
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.
Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, Albright A, Cheng JD, Kang SP, Shankaran V, Piha-Paul SA, Yearley J, Seiwert TY, Ribas A, McClanahan TK. Ayers M, et al. J Clin Invest. 2017 Aug 1;127(8):2930-2940. doi: 10.1172/JCI91190. Epub 2017 Jun 26. J Clin Invest. 2017. PMID: 28650338 Free PMC article. Clinical Trial.
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, Ye XS, Do IG, Liu S, Gong L, Fu J, Jin JG, Choi MG, Sohn TS, Lee JH, Bae JM, Kim ST, Park SH, Sohn I, Jung SH, Tan P, Chen R, Hardwick J, Kang WK, Ayers M, Hongyue D, Reinhard C, Loboda A, Kim S, Aggarwal A. Cristescu R, et al. Among authors: ayers m. Nat Med. 2015 May;21(5):449-56. doi: 10.1038/nm.3850. Epub 2015 Apr 20. Nat Med. 2015. PMID: 25894828
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028.
Ott PA, Bang YJ, Piha-Paul SA, Razak ARA, Bennouna J, Soria JC, Rugo HS, Cohen RB, O'Neil BH, Mehnert JM, Lopez J, Doi T, van Brummelen EMJ, Cristescu R, Yang P, Emancipator K, Stein K, Ayers M, Joe AK, Lunceford JK. Ott PA, et al. Among authors: ayers m. J Clin Oncol. 2019 Feb 1;37(4):318-327. doi: 10.1200/JCO.2018.78.2276. Epub 2018 Dec 13. J Clin Oncol. 2019. PMID: 30557521 Clinical Trial.
Hamartoma.
STEVENSON LB, AYERS MA. STEVENSON LB, et al. Among authors: ayers ma. Henry Ford Hosp Med Bull. 1958 Dec;6(4 Part 1):336-40. Henry Ford Hosp Med Bull. 1958. PMID: 13610287 Free article. No abstract available.
HER-2/neu testing in breast cancer.
Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Hortobagyi GN. Ross JS, et al. Among authors: ayers m. Am J Clin Pathol. 2003 Dec;120 Suppl:S53-71. doi: 10.1309/949FPQ1AQ3P0RLC0. Am J Clin Pathol. 2003. PMID: 15298144 Review.
Expanding etiology of progressive familial intrahepatic cholestasis.
Henkel SA, Squires JH, Ayers M, Ganoza A, Mckiernan P, Squires JE. Henkel SA, et al. Among authors: ayers m. World J Hepatol. 2019 May 27;11(5):450-463. doi: 10.4254/wjh.v11.i5.450. World J Hepatol. 2019. PMID: 31183005 Free PMC article.
155 results